As companies aim to cut costs and reel in spending amid uncertain macroeconomic conditions, Form Bio thinks it is actually the perfect time to launch its platform. The software company was developed at...
The venture and startup industries have long had a problem with transparency.
Theranos could have likely saved itself from a future fraud trial if it was honest about the shortcomings of its blood testing...
As venture funding continues to slow, founders are scrambling to extend their runways, regardless of how much cash they already have in the bank. But the startups that need the cash infusions the...
